Browse 100+ evidence-based profiles with community ratings, dosage guides, and safety information.
Start ExploringPublished 26 March 2026
Ashwagandha (Withania somnifera) is one of the most popular nootropics and adaptogens in the world. Millions of people take it daily for stress reduction, anxiety relief, sleep improvement, and cognitive support. Clinical trials consistently demonstrate benefits for cortisol reduction (23-30%), anxiety (comparable to lorazepam in some studies), sleep quality, and physical performance. But as its popularity has grown, so have questions about its long-term safety - particularly regarding liver health, thyroid function, and whether cycling is necessary.
This guide presents a thorough, evidence-based analysis of ashwagandha's safety profile, covering what the clinical trials actually show, the reported adverse effects, the specific populations who should exercise caution, and practical guidance for safe long-term use. For ashwagandha's benefits and mechanisms in detail, see its full nootropic profile.
The vast majority of ashwagandha RCTs (randomised controlled trials) have studied supplementation over 8-12 weeks, with a handful extending to 6-12 months. The longest published trials include:
In all published RCTs, ashwagandha has been well tolerated at doses of 300-600 mg daily over periods up to 12 weeks. Adverse events reported in trials are generally mild and comparable to placebo: occasional gastrointestinal discomfort, drowsiness, and headache. No studies have reported serious adverse events at standard doses.
The honest assessment is that we lack large-scale studies specifically designed to evaluate ashwagandha safety beyond 3 months. Traditional Ayurvedic use spans thousands of years, but historical use at unknown doses is not equivalent to modern controlled safety data. This evidence gap does not mean ashwagandha is unsafe long-term - it means we must rely on the totality of available evidence: clinical trial safety data, pharmacological understanding of its mechanisms, post-marketing surveillance, and case reports.
The most widely discussed safety concern is hepatotoxicity (liver damage). Several case reports have documented liver injury temporally associated with ashwagandha use:
These case reports are concerning but require careful contextualisation:
For long-term ashwagandha users, reasonable precautions include:
Ashwagandha has a well-documented effect on thyroid function - it increases circulating levels of T4 (thyroxine) and T3 (triiodothyronine). A 2018 study in the Journal of Alternative and Complementary Medicine found that ashwagandha (600 mg daily for 8 weeks) significantly increased TSH, T3, and T4 levels in subclinically hypothyroid patients, effectively normalising thyroid function. This is beneficial for people with subclinical hypothyroidism, but creates important considerations for others:
Multiple studies have shown ashwagandha increases testosterone levels in men, particularly those who are stressed or have low baseline levels. A 2019 RCT found a 14.7% increase in testosterone compared to placebo over 8 weeks. This is generally considered a benefit for men, but means ashwagandha may not be appropriate for hormone-sensitive conditions such as prostate cancer or in situations where testosterone elevation is undesirable.
Ashwagandha's most reliable effect is cortisol reduction, typically 23-30% in clinical trials. This is beneficial for chronically stressed individuals but raises a theoretical concern: prolonged cortisol suppression below normal levels could impair immune function, stress response capacity, and metabolic regulation. In practice, ashwagandha appears to normalise rather than suppress cortisol - bringing elevated levels down to the normal range rather than pushing them below it. However, this is another reason why periodic breaks may be prudent.
Ashwagandha has a relatively clean interaction profile compared to many herbal supplements, but several interactions warrant attention:
Cycling - taking periodic breaks from supplementation - is commonly recommended for ashwagandha, though the evidence base for this is more theoretical than empirical. The arguments for cycling include:
There is no definitive "correct" cycling protocol. The 8-weeks-on, 2-weeks-off approach provides a reasonable balance between sustained benefit and precautionary rest. If you experience consistent benefits without side effects and your doctor is comfortable with your lab values, longer continuous use is not unreasonable - but periodic breaks remain a sensible precaution.
Product quality is arguably the most important safety factor for long-term use. Key considerations:
For more guidance on evaluating supplement quality, see our How to Choose the Right Nootropic Brand guide.
Ashwagandha has a strong safety profile at standard doses (300-600 mg daily) based on clinical trial data spanning up to 12 weeks. The most significant concerns - rare liver injury and thyroid stimulation - are manageable with quality sourcing, appropriate dosing, and periodic monitoring. For most healthy adults, ashwagandha is safe for long-term use with cycling breaks. However, it is not appropriate for everyone: pregnant women, those with hyperthyroidism, active autoimmune disease, or liver impairment should avoid it. As with any long-term supplement, the combination of a quality product, sensible dosing, periodic breaks, and awareness of your body's responses provides the best framework for safe, sustained benefit.
For more on ashwagandha's mechanisms and benefits, see its full nootropic profile. For a comparison with another popular mood-supporting herb, see our Ashwagandha vs Saffron guide. For broader adaptogen context, see our Adaptogens Guide.
Clinical trials show ashwagandha (300-600 mg daily of KSM-66 or Sensoril extract) is well tolerated for up to 12 weeks of daily use, with side effects comparable to placebo. For ongoing daily use beyond this, cycling is recommended - 8 weeks on, 2 weeks off is the most common protocol. This allows the body's hormonal systems to recalibrate and reduces cumulative exposure. Many people take ashwagandha daily for years without issues, but periodic breaks and annual blood work (liver and thyroid panels) are sensible precautions.
Rare cases of liver injury have been reported in association with ashwagandha use, documented in medical literature and the NIH's LiverTox database. However, the incidence is very low given the millions of users worldwide, many cases involved multi-ingredient products or unregulated sources, and all reported cases resolved after stopping supplementation. To minimise risk, use reputable third-party tested brands (KSM-66 or Sensoril), stay within recommended dosages, avoid combining with excessive alcohol, and watch for warning signs like jaundice, dark urine, or persistent nausea.
Yes. Clinical studies confirm that ashwagandha increases T3 and T4 thyroid hormone levels. A 2018 study found it normalised thyroid function in subclinically hypothyroid patients. This is beneficial for people with underactive thyroid but means ashwagandha should be avoided by anyone with hyperthyroidism or Graves' disease. If you take thyroid medication (levothyroxine), ashwagandha could alter your effective dose, so consult your endocrinologist and monitor thyroid levels more frequently.
The most commonly recommended cycling protocol is 8 weeks on, 2 weeks off. This roughly matches the duration of most clinical trials and allows the HPA axis to recalibrate. Alternative protocols include 5 days on / 2 days off (gentler, with continuous benefit) or 3 months on / 1 month off (fewer interruptions). There is no single "correct" protocol - choose one that fits your routine and reassess periodically whether you still notice benefits. The break also lets you evaluate whether ashwagandha is genuinely helping or has become habitual.
Ashwagandha should be avoided by pregnant or breastfeeding women, people with hyperthyroidism or Graves' disease, those with active liver disease, and anyone with a nightshade allergy (ashwagandha is in the Solanaceae family). People taking immunosuppressants, sedatives, thyroid medication, or diabetes drugs should consult their doctor first due to potential interactions. Discontinue at least 2 weeks before scheduled surgery. If you have an autoimmune condition, discuss with your doctor as the immunomodulatory effects may or may not be appropriate for your specific situation.